Tests an individual psychoeducation program for people with schizophrenia in hospital
Tests an individual early education program for inpatients with schizophrenia, aged 18 to 65.
Plain-language title generated from the registry record
Registry title: Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients
Key facts
- Where
- Blois, Chinon, Dreux, Fleury-les-Aubrais, La Roche-sur-Yon, Neuilly-sur-Marne, Rennes, Saint-Maurice, Sainte-Gemmes-sur-Loire, Sotteville-lès-Rouen, and Tours, FranceSee the 11 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT05329363, who can take part
Where in France
- Serrvice de PsychiatrieBlois, FranceNo longer taking part
- Service de psychiatrieChinon, FranceTaking people
- Service de psychiatrieDreux, FranceNot yet recruiting
- Service de psychiatrieFleury-les-Aubrais, FranceNo longer taking part
- Service de psychiatrieLa Roche-sur-Yon, FranceTaking people
- Service de psychiatrieNeuilly-sur-Marne, FranceNot yet recruiting
- Service de psychiatrieRennes, FranceTaking people
- Service de psychiatrieSaint-Maurice, FranceNot yet recruiting
- Service de psychiatrieSainte-Gemmes-sur-Loire, FranceTaking people
- Service de psychiatrieSotteville-lès-Rouen, FranceNot yet recruiting
- Service de psychiatrieTours, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Tours
- Trial code
- NCT05329363
- Record updated
- 23 April 2024
- Original description
Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life. Indeed, many patients relapse with exacerbation of symptoms.Read full original descriptionShow less
Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients: A Randomized, Multicenter Trial
Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life. Indeed, many patients relapse with exacerbation of symptoms.
Psychoeducation can improve therapeutic alliance and medication compliance.
In this context, an individual psycho-education program (PEPITS) has been developed. PEPITS carried out by nurses during the initial stages of hospitalisation.
The hypothesis is that PEPITS program will decrease relapse and improve the compliance and insight and and so the quality of life.
Inclusion: Age between 18 and 65 years; Patient with a diagnosed and reported schizophrenic disorder announced :; Schizophrenia; Schizoaffective disorder; Or a diagnosed and reported Delusional Disorder; Express written consent by the participant after receiving information about the study; Be able to communicate verbally; Participant affiliated to a social security scheme.
Exclusion: Pregnant or breastfeeding woman; Patient who does not speak French; Participation in a psycho-education group in the last 2 years; Patient under legal protection or guardianship.